Malignant Rectal Polyp

Slides:



Advertisements
Similar presentations
Surveillance/ Screening Colonoscopy for Colorectal Cancer
Advertisements

Neoadjuvant therapy for Rectal cancer
Follow-up of GI Cancers Dr. Marianne Taylor BC Cancer Agency – CSI November 29, 2003.
Diagnosis.
IN THE NAME OF GOD. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy The American Journal.
Taunton SpR Training Day 7th December 2012 Early rectal cancer
North Tees University Hospital Audit of T1 Rectal Cancers September 2013 – August 2014 Nicola Maguire Teaching fellow General Surgery 12/09/2014.
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Polyps – Where do they come from and what do you do with them?!
Management of Malignant Polyps Santhat Nivatvongs, MD Colon and Rectal Surgery Mayo Clinic Rochester Minnesota U.S.A.
Endoscopic Ultrasound in Rectal Cancer Natasha Schneider November 15, 2010.
AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
Rectal Cancer: A Complete Clinical Response…Now what?
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Management of large rectal adenoma Dr. Hester YS Cheung Department of surgery Pamela Youde Nethersole Eastern Hospital.
AJCC TNM Staging 7th Edition Colon Case #1
The Adenoma/Carcinoma Sequence in the Colon
Management of a rare type of Ca appendix Dr. Lam Tang Yu Tuen Mun Hospital Joint Hospital Surgical Grand Round.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Malignant colonic polyp: endoscopic treatment updates
Joint Hospital Surgical Grand Round 19 June 2004.
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Role of Neck Dissection for Differentiated Thyroid CA Joint Hospital Surgical Grand Round NDH Dr. Alex TSANG.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Treatment of Early Malignant Rectal Polyp
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Colorectal carcinoma Dr.Mohammadzadeh.
Resection For Lung Metastases M62 Coloproctology Course.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院 大腸直腸外科 葉重宏.
Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.
A. MONTORI M.D. F.A.C.S. PROFESSOR OF SURGERY UNIVERSITY OF ROME “LA SAPIENZA” President of EAcSS HOW TO AVOID MAJOR SURGERY IN RECTAL CANCER MSO-MTCC.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
Potentially curative re-resection of recurrent CRC  Suture line recurrences  Isolated liver metastases  Isolated pulmonary metastases.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Datum/Vortragsthema Local resection of Rectum tumors Peter M. Markus Elisabeth Hospital Essen Germany.
LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
MALIGNANT POLYPS DURING THE FIRST THREE SCREENING ROUNDS ( ) FOR COLON-RECTAL CANCER (CRC) IN A NORTH-EASTERN SANITARY DISTRICT (ULSS-1 VENETO).
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Role of MRI in Primary Rectal Cancer Staging and Management
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Kyung Hee University, Seoul, Korea Conference LGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Karcinom rektuma- management
Non-operative Management of Rectal Cancer
Treatment of superficial neoplastic lesion of esophagus
Department of General Surgery, Upper Gastrointestinal Unit,
Dr.Amit Gupta Associate Professor Dept. of Surgery
Survival analysis of Local excision versus Radical resection for Early-stage Middle and Low Rectal cancer 早期中低位直腸癌的治療: 局部切除與根治性切除之預後分析 賴以立 唐瑞平 陳進勛 游正府.
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Dr Jessica Jenkins Consultant Oncologist
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
Polyps of the Colon and Rectum
The STAR-TREC Trial SIV Presentation
Presentation transcript:

Malignant Rectal Polyp Joint Hospital Surgical Grand Round 18 Apr 2009 Malignant Rectal Polyp Dr Kit-wai Lai Department of Surgery Tuen Mun Hospital

Malignant Rectal Polyp Polyps with cancer cells penetrating the muscularis mucosa Invasion limited to submucosa i.e. T1 lesion

Size the most important factor determining risk of malignant transformation within a polyp Tytherleigh et al. BJS 2008;95:409-423 >1cm 38.5% >42mm 78.9%

Haggitt Classification Level 0: noninvasive (severe dysplasia) Level 1: invading through the muscularis mucosa but limited to the head of a pedunculated polyp Level 2: invading the neck of a pedunculated polyp Level 3: invading the stalk of a pedunculated polyp Level 4: invading into the submucosa below the stalk of a pedunculated polyp ( Sessile malignant polyplevel 4 ) All sessile polyps with invasive cancer are level 4

Kikuchi Classification of Adenocarcinoma in Sessile Polyp Haggitt level 1,2,3 = Kikuchi Sm1 level 4 = Sm1, Sm2 or Sm3

 Local Therapy Opportunity of cure with less detriment Staging is critical to management Histological Assessment Most important factor to predict risk of lymphatic spread  Local Therapy Opportunity of cure with less detriment Tytherleigh et al. BJS 2008;95:409-423

Histopathological Features Low-risk ERC High-risk ERC Depth of wall invasion Haggitt 1-3 Kikuchi Sm1 & (possibly Sm2) Kikuchi Sm3 & (possibly Sm2) Grade Well Moderate differentiated Poorly differentiated Undifferentiated Lymphovascular invasion - + Best estimate of the probability of regional LN metastasis Bretagnol et al. Dis Colon Rectum 2007;50:523-533 Rate of lymph node metastasis Sm1 1-3% Sm2 8% Sm3 23% Nascimbeni et al. Dis Colon Rectum 2002;45:200-206 Poorly differentiated 43% Goldstein et al. Am J Clin Pathol 1999;111:51-8 Depth: best estimate of the probability of regional LN metastasis Grade of initial bx may be diff from excised specimen Moderate 20% *Risk of LN metastasis vs sm1/2/3: Nascimbeni, Kikuchi *Nascimbeni et al. [15] studied histological specimens retrospectively from 353 patients undergoing colorectal resection for sessile T1 lesions.(1979-1995) The authors reported that the depth of invasion into the lower third of the submucosa (classified as ‘sm3’), the presence of lymphovascular invasion, and lesions in the lower third of the rectum were significant predictors of lymph node metastasis *(St Marks) S. Rasheed et al. Colorectal Disease, 10, 231–237. (1971-96)total 313 T1 in 55 (18.2%) and T2 in 248 (81.2%). The node positive group did however contain a significantly higher number of patients with poorly differentiated tumours (P = 0.001) and patients with evidence of extramural vascular invasion (P = 0.002). Finally there was no significant difference in the number of patients with sm1, sm2, sm3(12-14%), or T2 (~19%) tumour depths within the lymph node positive and negative groups Limitation: small sample size of T1, retrospective, surgeon choose for radical excision rather than local excision

Clinical Scenario 1. Post Colonoscopic polypectomy of rectal polyp Colonoscopy: 2.5cm rectal polyp (3cm from anal verge) Biopsy: adenocarcinoma 2. Post Colonoscopic polypectomy of rectal polyp Pathology: adenocarcinoma arise from tubular adenoma

Clinical Scenario 1. Colonoscopy: 2.5cm rectal polyp (3cm from anal verge) Biopsy: adenocarcinoma

Scenario 1 2.5cm rectal Polyp Digital rectal exam ERUS MRI CT LN + LN - Radical Sx AR/TME/APR T2 T1 Local Excision + Adj ChemoRT High Risks Features Sm3 (Sm2) Grade lymphovascular No High Risks Features Follow-up Recurrence No Recurrence Salvage Surgery APR for an ERC should be unusual as there are many sphincter-preserving techniques that can be empolyed Pt’s choice, co-morbidity, body habitus will also affect tx decision Local excision + adj chemoRT for T2 and high risk T1: assuming that further surgery is not an option

ERUS Best method to determining T stage T stage N stage Accuracy: 90 % Sensitivity : 85% Specificity: 95% N stage Accuracy: 80% Sensitivity: 70% Specificity: 80% hypoechoic nodes with short axis diameters of 5 mm or more, nodes of any diameter with heterogeneous echogenicity, or hypoechoic nodes of any diameter in cases with biopsy-proven Bretagnol et al. Dis Colon Rectum 2007;50:523-533

ERUS T1-slight (Sm1) detection Sensitivity (99%) Specificity (74%) Accuracy (96%) Akasu et al. World J Surg 2000;24:1061-1068 May assess residual tumour following polypectomy Follow up after local excision or radical surgery Hernandez De Anda et al. Dis Colon Rectum 2004; 47: 818–824 Limitations Sm1 Operator dependent Tumor height Tumour stenosis Peritumoral fibrosis and inflammatory tissue Effect of pre op radiotherapy or haemorrhage in bowel wall after bx Sensitivity/specificity/overall accuracy rates for detection of slight submucosal invasion, massive submucosal invasion, and muscularis propria invasion were 99%/ 74%/96%, 98%/88%/97%, and 97%/93%/96%, respectively Limitations: peritumoral fibrosis and inflammatory tissue, operator dependent, tumor height, tumour stenosis, effect of pre op radiotherapy or haemorrhage in bowel wall after bx -the substitution of the typical five-layer structure of the rectal wall by a mixed echoic pattern involving a segment of the rectal wall. The staples after an anastomosis are usually visualized as a circumferential line of small, bright echoes without a shadow. Local recurrence often appears as a well-defined hypoechoic homogenous mass involving the rectal wall or as a hypoechoic extrarectal node, persisting in at least two consecutive exams (Figs. 1 and 2). Recurrence was confirmed by endoscopic biopsy, ultrasound-guided biopsy, or CT scan-guided biopsy. Sm2

MRI Overall T stage accuracy 59-95% T1,2 lesion (vs ERUS) N stage Similar sensitivities Lower specificity (69%) N stage Comparable vs ERUS Endorectal and phased-array coils--> better resolution and accuracy for predicting tumour stage New techniques accuracy ~ 90% A meta analysis: T1, 2 lesion: ERUS, MRI smilar sensitivities, ERUS 86% specificity sig higher MRI69% Bretagnol et al. Dis Colon Rectum 2007;50:523-533

Scenario 1 2.5cm rectal Polyp Digital rectal exam ERUS MRI CT LN - LN + T1 T2 Local Excision High Risks Features Sm3 (Sm2) Grade lymphovascular No High Risks Features APR for an ERC should be unusual as there are many sphincter-preserving techniques that can be empolyed Pt’s choice, co-morbidity, body habitus will also affect tx decision Local excision + adj chemoRT for T2 and high risk T1: assuming that further surgery is not an option Follow-up Local Excision + Adj ChemoRT Radical Sx AR/TME/APR Recurrence No Recurrence Salvage Surgery

Local Excision Potential advantage Sphincter preservation Minimal mortality and morbidity Low urinary/sexual dysfunction risk

Local Excision Parks’ Per Anal Excision Lesions 6-10cm from anal verge Aid of anal retractors Full thickness excision Transanal Endoscopic Microsurgery Resectoscope Usual below peritoneal reflection Snare polypectomy or endoscopic mucosal resection is used to treat polyps that are thought to be benign. A polyp that does not ‘lift’ on submucosal infiltration should be regarded as malignant ???peritoneal reflection

Local Excision LR Bretagnol et al. Dis Colon Rectum 2007;50:523-533

Local Excision vs Radical Sx T1sm3 lesion Radical Surgery had lower rates of distant metastasis and better survival Bretagnol et al. Dis Colon Rectum 2007;50:523-533 NASCIMBENI ET AL Dis Colon Rectum 2004; 47: 1773–1779 We compared 70 patients who underwent local excision with 74 patients who underwent oncologic resection. Among patients with lesions in the middle or lower third of the rectum, 1) the five-year and ten-year outcomes were significantly better for overall survival and cancer-free survival in the oncologic resection group, but there were no significant differences in local recurrence or distant metastasis; 2) the multivariate risk factors for long-term, cancer-free survival were invasion into the lower third of the submucosa, local excision, and older than aged 68 years; and 3) for lesions with invasion into the lower third of the submucosa, the oncologic resection group had lower rates of distant metastasis and better survival. Among patients with lesions in the lower third of the rectum, 1) the five-year and tenyear outcomes showed no significant differences in survival, local recurrence, or distant metastasis between the two groups; and 2) for lesions with invasion into the lower third of the submucosa, the oncologic resection group showed a trend of improved survival, which was not statistically significant, possibly because of low statistical power from the small sample size

Scenario 1 2.5cm rectal Polyp Digital rectal exam ERUS MRI CT LN - LN + T1 T2 Local Excision High Risks Features Sm3 (Sm2) Grade lymphovascular No High Risks Features APR for an ERC should be unusual as there are many sphincter-preserving techniques that can be empolyed Pt’s choice, co-morbidity, body habitus will also affect tx decision Local excision + adj chemoRT for T2 and high risk T1: assuming that further surgery is not an option Follow-up Local Excision + Adj ChemoRT Radical Sx AR/TME/APR Recurrence No Recurrence Salvage Surgery

Adjuvant chemoradiotherapy Limited data May be helpful If further surgery is not an option T1 lesions with adverse pathologic features T2 lesions (Tytherleigh et al. BJS 2008;95:409-423) Difficult to interpret Most retrospective studies Lack of controlled data Adjuvant regime not always based on a defined protocol Difficult to interpret Most series retrospective studies with heterogeneous gp of pt n lack of controlled data adjuvant regime is not always based on a defined protocol In conclusion, the limited data suggest that adjuvant chemoradiotherapy may be helpful in patients with T1 lesions with adverse pathologic features and T2 lesions, achieving a local recurrence rate < 20 percent. Bretagnol et al. Dis Colon Rectum 2007;50:523-533

Scenario 1 2.5cm rectal Polyp Digital rectal exam ERUS MRI CT LN - LN + T1 T2 Local Excision High Risks Features Sm3 (Sm2) Grade lymphovascular No High Risks Features APR for an ERC should be unusual as there are many sphincter-preserving techniques that can be empolyed Pt’s choice, co-morbidity, body habitus will also affect tx decision Local excision + adj chemoRT for T2 and high risk T1: assuming that further surgery is not an option Follow-up Local Excision + Adj ChemoRT Radical Sx AR/TME/APR Recurrence No Recurrence Salvage Surgery

Follow up Regular endoscopic surveillance of rectum and scar Digital rectal exam + Endoscopy + CEA First 2 years: every 3 months Next 3 years: every 6 months Then annually National comprehensive Cancer Network guidelines recommended for T1 with local excision Q3m x 2yr Q6m x 3 yr q1y Mellgren et al. Dis Colon Rectum 2000; 43: 1064–1071 NCCN guideline

Follow up ERUS Advisable Frequency: subject to debate One study showed More isolated local recurrence in the follow-up ERUS group underwent Salvage Surgery (44% vs 23 %), but the differences were not significant Hernandez De Anda et al. Dis Colon Rectum 2004; 47: 818–824 ERUS every four months for the first three years and every six months for the two years after curative surgery

Scenario 1 2.5cm rectal Polyp Digital rectal exam ERUS MRI CT LN - LN + T1 T2 Local Excision High Risks Features Sm3 (Sm2) Grade lymphovascular No High Risks Features APR for an ERC should be unusual as there are many sphincter-preserving techniques that can be empolyed Pt’s choice, co-morbidity, body habitus will also affect tx decision Local excision + adj chemoRT for T2 and high risk T1: assuming that further surgery is not an option Follow-up Local Excision + Adj ChemoRT Radical Sx AR/TME/APR Recurrence No Recurrence Salvage Surgery

Recurrence Long-term FU beyond 10 years is necessary Unresected disease in regional lymphatics cause local failure Diagnose early for salvage surgery Tytherleigh et al. BJS 2008;95:409-423

Salvage Surgery 56-100% of patients with recurrence suitable for salvage surgery Results controversial May not afford same outcomes as initial classical treatment Decreased survival if resection is delayed at time of recurrence (for adverse pathology of local excision specimen) Disease free survival rates 20-35% Mellgren et al. Dis Colon Rectum 2000; 43: 1064–1071

Clinical Scenario 2. Colonoscopic polypectomy of rectal polyp Pathology: adenocarcinoma arise from tubular adenoma

Scenario 2 Post polypectomy (Adenoca arise from TA) No High Risks Features Haggitt level 1,2,3 Kikuchi Sm1 High Risks Features Sm3 (Sm2) Grade lymphovascular ERUS MRI CT LN- LN+ Margin involvement Yes Histological assessment not adequate No Local Excision No Yes Follow up Radical Surgery High Risks Features

Summary Staging and Adequate Histological Assessment is crucial in management of malignant rectal polyp

Summary Local excision Radical Surgery Recurrence Recommended for low risk T1 sm1 lesion Adjuvant therapy considered in high risk T1, T2 if surgery not an option Radical Surgery Recommended for high risk T1 , T2 lesion Recurrence Diagnose early for salvage surgery

Thank You